1. Home
  2. CRNX vs SKYH Comparison

CRNX vs SKYH Comparison

Compare CRNX & SKYH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Crinetics Pharmaceuticals Inc.

CRNX

Crinetics Pharmaceuticals Inc.

HOLD

Current Price

$38.24

Market Cap

3.9B

Sector

Health Care

ML Signal

HOLD

Logo Sky Harbour Group Corporation

SKYH

Sky Harbour Group Corporation

HOLD

Current Price

$10.55

Market Cap

368.1M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRNX
SKYH
Founded
2008
2017
Country
United States
United States
Employees
N/A
112
Industry
Biotechnology: Pharmaceutical Preparations
Military/Government/Technical
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
3.9B
368.1M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
CRNX
SKYH
Price
$38.24
$10.55
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
4
Target Price
$76.63
$13.13
AVG Volume (30 Days)
948.2K
105.0K
Earning Date
05-07-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,039,000.00
N/A
Revenue This Year
$720.10
$78.89
Revenue Next Year
$184.67
$73.15
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$25.83
$8.22
52 Week High
$57.99
$12.20

Technical Indicators

Market Signals
Indicator
CRNX
SKYH
Relative Strength Index (RSI) 47.72 57.99
Support Level $33.19 $9.76
Resistance Level $45.32 $10.78
Average True Range (ATR) 1.32 0.34
MACD 0.11 -0.03
Stochastic Oscillator 37.22 54.00

Price Performance

Historical Comparison
CRNX
SKYH

About CRNX Crinetics Pharmaceuticals Inc.

Crinetics Pharmaceuticals Inc is a commercial-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its main product, Palsonify (paltusotine), is a once-daily, oral treatment approved by the FDA for adults with acromegaly who have had an inadequate response to surgery and/or for whom surgery is not an option. Additionally, the company's development pipeline includes several programs, including a late-stage investigational candidate, atumelnant, currently in development for CAH and ADCS, and CRN09682, a NDC candidate that is being developed to treat SST2-expressing NETs and other SST2-expressing solid tumors.

About SKYH Sky Harbour Group Corporation

Sky Harbour Group Corp is an aviation infrastructure company focused on building the first nationwide network of Home Base Operator (HBO) campuses designed exclusively for business aircraft. The company develops, leases, and manages general aviation hangars across the United States, targeting airfields in markets with aircraft populations and high hangar demand. Its HBS campuses include private hangars and offer a range of services tailored to aircraft owners operating from these facilities. The majority of the company's revenue is derived from the leasing of home-based aircraft hangars and through services and products ancillary to its leasing activities.

Share on Social Networks: